Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

Abstract

Treatment with ximelagatran, 36 mg twice daily, is associated with a lower risk of bleeding than warfarin in patients with nonvalvular atrial fibrillation. Aspirin use and increasing age were associated with an increased risk of bleeding in ximelagatran- and warfarin-treated patients.

Keywords

XimelagatranWarfarinMedicineAtrial fibrillationStroke (engine)Direct thrombin inhibitorHazard ratioAnticoagulantInternal medicineAnesthesiaConfidence intervalCardiologyDabigatran

MeSH Terms

AdolescentAdultAgedAnticoagulantsAtrial FibrillationAzetidinesBenzylaminesFemaleFollow-Up StudiesHemorrhageHumansIncidenceMaleMiddle AgedRisk FactorsSurvival RateThrombosisTime FactorsTreatment OutcomeWarfarin

Affiliated Institutions

Related Publications

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

John W. Eikelboom , Lars Wallentin , Stuart J. Connolly +13 more

Background— Dabigatran 150 and 110 mg twice a day and warfarin are effective for stroke prevention in atrial fibrillation. The purpose of this study was to compare their risks o...

2011 Circulation 1071 citations

Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?

Lawrence Baruch , Brian F. Gage , Jay Horrow +4 more

Background and Purpose— Patients with atrial fibrillation have a varied risk of stroke, depending on age and comorbid conditions. The objective of this study was to assess the p...

2007 Stroke 71 citations

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel , Kenneth W. Mahaffey , Jyotsna Garg +13 more

In patients with atrial fibrillation, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism. There was no significant between-group differenc...

2011 New England Journal of Medicine 9184 citations

Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

Gregory W. Albers , Hans‐Christoph Diener , Lars Frison +8 more

The results establish the efficacy of fixed-dose oral ximelagatran without coagulation monitoring compared with well-controlled warfarin for prevention of thromboembolism in pat...

2005 JAMA 660 citations

Low-Dose Aspirin for Prevention of Stroke in Low-Risk Patients With Atrial Fibrillation

Hiroshi Sato , Kinji Ishikawa , Akira Kitabatake +15 more

Background and Purpose— Although the efficacy of anticoagulant therapy for primary prevention of stroke in patients with nonvalvular atrial fibrillation (NVAF) has been establis...

2005 Stroke 280 citations

Publication Info

Year: 2006
Type: article
Volume: 166
Issue: 8
Pages: 853-853
Citations: 88
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Influential

CrossRef

Cite This

APA Style

                            
                                
                                    James D. Douketis, 
                                
                                    Karin Arneklev, 
                                
                                    Samuel Z. Goldhaber
                                
                                et al.
                            
                            (2006). 
                            Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin. 
                            Archives of Internal Medicine
                            , 166
                            (8)
                            , 853-853.
                            https://doi.org/10.1001/archinte.166.8.853
                        

Identifiers

DOI: 10.1001/archinte.166.8.853
PMID: 16636210

Data Quality

Data completeness: 81%